论文部分内容阅读
目的:探讨孟鲁司特治疗咳嗽变异性哮喘的临床疗效。方法:选取2014年6月至2015年3月在我院诊治的咳嗽变异性哮喘患者76例,采用随机表法将患者分为研究组(36例)和对照组(40例),对照组采用常规治疗,研究组在常规的治疗的基础上加用孟鲁司特咀嚼片治疗,分析两组患者临床疗效。结果:对照组痊愈10例、有效9例、显效6例、无效15例,总有效率62.5%;研究组痊愈13例、有效12例、显效6例、无效5例,总有效率86.1%,两组比较差异有显著性(P<0.05)。结论:孟鲁司特治疗咳嗽变异性哮喘可以缓解哮喘症状,提高治疗哮喘的临床效果,值得广泛推广应用。
Objective: To investigate the clinical efficacy of montelukast in the treatment of cough variant asthma. Methods: Sixty-six patients with cough variant asthma diagnosed and treated in our hospital from June 2014 to March 2015 were randomly divided into the study group (36 cases) and the control group (40 cases), and the control group Routine treatment, the study group in the conventional treatment based on the addition of montelukast chewable tablets, the clinical efficacy of two groups were analyzed. Results: In the control group, 10 cases were cured, 9 cases were effective, 6 cases were markedly effective, 15 cases were ineffective and the total effective rate was 62.5%. In the study group, 13 cases were cured, 12 cases were effective, 6 cases markedly effective and 5 cases ineffective with a total effective rate of 86.1% There was significant difference between the two groups (P <0.05). Conclusion: Montelukast treatment of cough variant asthma can relieve the symptoms of asthma and improve the clinical efficacy of treatment of asthma, which deserves wide application.